We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
+26.22%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$246B
AUM Growth
+$40.4B
(+20%)
Cap. Flow
-$3.46B
Cap. Flow
% of AUM
-1.41%
Top 10 Holdings %
Top 10 Hldgs %
22.52%
Holding
3,466
New
266
Increased
1,402
Reduced
1,481
Closed
200
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$613M |
| 2 |
Match Group
MTCH
|
+$518M |
| 3 |
Meta Platforms (Facebook)
META
|
+$508M |
| 4 |
RTX Corp
RTX
|
+$456M |
| 5 |
Eli Lilly
LLY
|
+$364M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$828M |
| 2 |
Microsoft
MSFT
|
+$510M |
| 3 |
Gilead Sciences
GILD
|
+$465M |
| 4 |
Merck
MRK
|
+$376M |
| 5 |
Walmart Inc
WMT
|
+$369M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.64% |
| 2 | Healthcare | 14.1% |
| 3 | Financials | 12.4% |
| 4 | Consumer Discretionary | 12.19% |
| 5 | Communication Services | 9.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1951
Universal Corp
UVV
$1.27B
| $4.53M | ﹤0.01% |
106,571
+11,513
| +12% | +$506K |
|
1952
Theravance Biopharma
TBPH
$877M
| $4.53M | ﹤0.01% |
215,653
-86,492
| -29% | -$2.22M |
|
1953
iHeartMedia
IHRT
$583M
| $4.51M | ﹤0.01% |
540,742
+523,883
| +3,107% | +$4.08M |
|
1954
Hope Bancorp
HOPE
$1.79B
| $4.51M | ﹤0.01% |
489,444
+21,899
| +5% | +$196K |
|
|
RWT
1955
Redwood Trust
RWT
$594M
| $4.5M | ﹤0.01% |
643,256
-6,206
| -1% | -$30.6K |
|
1956
Enterprise Financial Services Corp
EFSC
$2.39B
| $4.5M | ﹤0.01% |
144,668
-38,535
| -21% | -$1.12M |
|
1957
QCR Holdings
QCRH
$1.7B
| $4.48M | ﹤0.01% |
143,776
-14,925
| -9% | -$430K |
|
|
CIO
1958
DELISTED
City Office REIT
CIO
| $4.48M | ﹤0.01% |
445,358
-986,246
| -69% | -$9.12M |
|
1959
Acushnet Holdings
GOLF
$5.45B
| $4.48M | ﹤0.01% |
128,764
-11,262
| -8% | -$334K |
|
1960
Standard BioTools
LAB
$314M
| $4.48M | ﹤0.01% |
1,117,154
+48,584
| +5% | +$169K |
|
1961
Trinity Industries
TRN
$2.38B
| $4.47M | ﹤0.01% |
209,987
-9,025
| -4% | -$174K |
|
|
IMGN
1962
DELISTED
Immunogen Inc
IMGN
| $4.46M | ﹤0.01% |
969,523
-345,483
| -26% | -$1.47M |
|
|
ATNX
1963
DELISTED
Athenex, Inc. Common Stock
ATNX
| $4.46M | ﹤0.01% |
16,204
-894
| -5% | -$189K |
|
1964
Under Armour
UAA
$2.6B
| $4.45M | ﹤0.01% |
457,029
-30,774
| -6% | -$292K |
|
|
GOOD
1965
Gladstone Commercial Corp
GOOD
$627M
| $4.43M | ﹤0.01% |
236,287
-17,044
| -7% | -$279K |
|
1966
Enerpac Tool Group
EPAC
$1.93B
| $4.42M | ﹤0.01% |
251,389
-1,837
| -0.7% | -$31K |
|
1967
City Holding Co
CHCO
$2.04B
| $4.42M | ﹤0.01% |
67,838
+2,365
| +4% | +$150K |
|
|
RESI
1968
DELISTED
Front Yard Residential Corporation Common Stock
RESI
| $4.42M | ﹤0.01% |
507,501
-20,246
| -4% | -$185K |
|
1969
Westlake Corp
WLK
$9.9B
| $4.41M | ﹤0.01% |
82,199
-7,349
| -8% | -$338K |
|
1970
BancFirst
BANF
$3.8B
| $4.41M | ﹤0.01% |
108,663
-7,361
| -6% | -$270K |
|
1971
S&T Bancorp
STBA
$1.79B
| $4.4M | ﹤0.01% |
187,561
+31,791
| +20% | +$770K |
|
1972
Park National Corp
PRK
$3.67B
| $4.39M | ﹤0.01% |
62,446
+7,856
| +14% | +$575K |
|
|
UHT
1973
Universal Health Realty Income Trust
UHT
$594M
| $4.37M | ﹤0.01% |
56,197
-69
| -0.1% | -$6.5K |
|
1974
BGC Group
BGC
$4.89B
| $4.37M | ﹤0.01% |
1,594,114
+652,619
| +69% | +$1.81M |
|
|
GCP
1975
DELISTED
GCP Applied Technologies Inc.
GCP
| $4.35M | ﹤0.01% |
234,233
-46,414
| -17% | -$833K |
|
Similar funds
VFT
Nuveen's Q2 2020 Portfolio in Review
As of Q2 2020, Nuveen held 3,466 positions worth $246B, up 20% from $205B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Nuveen's Q2 2020 filing shows 266 new, 1,402 increased, 1,481 reduced and 200 closed positions. Its largest new stake was Zoom: 841,153 shares worth $213M. The largest sale was Amazon, an estimated $828M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.
- Nuveen's largest Q2 2020 buy was Zoom: 841,153 shares worth $213M.
- Nuveen added most to AbbVie in Q2 2020, an estimated $613M increase.
- Nuveen's biggest Q2 2020 reduction was Amazon, cutting an estimated $828M.
- Nuveen fully exited Allergan plc in Q2 2020, selling an estimated $212M.
- Nuveen's ten largest holdings make up 23% of its $246B portfolio in Q2 2020.
- Nuveen opened 266 new positions and closed 200 in Q2 2020.
- Nuveen's portfolio value rose 20% quarter-over-quarter to $246B.
Based on Nuveen's 13F filing for Q2 2020, filed 14 Aug 2020.